Product
Flu Seasonal mRNA Formulation
Aliases
GSK4382276A
1 clinical trial
2 indications
Indication
InfluenzaIndication
HumanClinical trial
A Phase 2a Randomized, Observer-blind, Dose-finding Study to Evaluate the Immunogenicity and Safety of mRNA-based Multivalent Seasonal Influenza Vaccine Candidates in Adults 18 Years of Age and OlderStatus: Recruiting, Estimated PCD: 2024-07-30